Vivaldi Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-147,393
Closed -$12.8M 145
2026
Q1
$12.8M Sell
147,393
-9,866
-6% -$945K 1.77% 15
2025
Q4
$15.1M Sell
157,259
-5,383
-3% -$523K 2.05% 13
2025
Q3
$15.5M Sell
162,642
-14,272
-8% -$1.31M 2.19% 10
2025
Q2
$15.4M Sell
176,914
-1,756
-1% -$149K 2.32% 8
2025
Q1
$16.1M Sell
178,670
-8,912
-5% -$797K 2.59% 5
2024
Q4
$17.3M Buy
+187,582
New +$16.2M 2.66% 6
2021
Q1
Sell
-1,800
Closed -$211K 373
2020
Q4
$211K Hold
1,800
0.05% 233
2020
Q3
$202K Buy
+1,800
New +$181K 0.04% 244

Other funds holding MDT

Vivaldi Capital Management's MDT Position: Q2 2026 in Review

Vivaldi Capital Management sold out of Medtronic (MDT) in Q2 2026, closing a stake of 147,393 shares — an estimated $12.8M sold.

Vivaldi Capital Management first reported a position in MDT in Q3 2020 and held it in 8 quarters. The position peaked at $17.3M in Q4 2024. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vivaldi Capital Management reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Vivaldi Capital Management sold 147,393 Medtronic shares in Q2 2026, an estimated $12.8M.
  • Vivaldi Capital Management first reported a position in Medtronic in Q3 2020 and held it in 8 quarters.
  • Vivaldi Capital Management's Medtronic position peaked at $17.3M in Q4 2024.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vivaldi Capital Management's 13F filing for Q2 2026.